513
  Mrv0541 02231214442D          

  9  8  0  0  0  0            999 V2000
    2.0930    0.6188    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    2.8075   -0.6188    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    7.0944    0.2063    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    4.9509    0.6188    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.2365    0.2063    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.6655    0.2063    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.5220    0.6188    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.3799    0.6188    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.8075    0.2063    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  9  1  0  0  0  0
  2  9  2  0  0  0  0
  3  8  1  0  0  0  0
  4  5  1  0  0  0  0
  4  6  1  0  0  0  0
  5  7  1  0  0  0  0
  6  8  1  0  0  0  0
  7  9  1  0  0  0  0
M  END
> <DRUGBANK_ID>
DB00513

> <DRUG_GROUPS>
approved; investigational

> <GENERIC_NAME>
Aminocaproic Acid

> <SYNONYMS>
6-aminohexanoic acid; Acide aminocaproïque; Ácido aminocapróico; Acidum Aminocaproicum; Aminocapronsäure; Eaca; EACA; Epsilcapramine; Epsilon-Aminocaproic Acid

> <BRANDS>
Acepramin; Amicar; Amocap; Caproamin; Caprocat; Caprolisin; E-Capro; Epsicaprom; Hemocid; Inselon; Ipron; Ipsilon; Kai Nai Yin; Minocap; Plaslloid; Resplamin

> <CHEMICAL_FORMULA>
C6H13NO2

> <MOLECULAR_WEIGHT>
131.1729

> <EXACT_MASS>
131.094628665

> <IUPAC_NAME>
6-aminohexanoic acid

> <IUPAC_TRADITIONAL_NAME>
aminocaproic acid

> <INCHI_IDENTIFIER>
InChI=1S/C6H13NO2/c7-5-3-1-2-4-6(8)9/h1-5,7H2,(H,8,9)

> <INCHI_KEY>
InChIKey=SLXKOJJOQWFEFD-UHFFFAOYSA-N

> <SMILES>
NCCCCCC(O)=O

> <JCHEM_ACCEPTOR_COUNT>
3

> <JCHEM_DONOR_COUNT>
2

> <JCHEM_ACIDIC_PKA>
4.73

> <JCHEM_BASIC_PKA>
10.21

> <JCHEM_PHYSIOLOGICAL_CHARGE>
0

> <ALOGPS_LOGP>
-2.7

> <JCHEM_LOGP>
-2

> <ALOGPS_LOGS>
-0.46

> <JCHEM_POLARIZABILITY>
14.71

> <JCHEM_POLAR_SURFACE_AREA>
63.32

> <JCHEM_REFRACTIVITY>
34.66

> <JCHEM_ROTATABLE_BOND_COUNT>
5

> <ALOGPS_SOLUBILITY>
4.52e+01 g/l __ 

$$$$
